Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit

Stopped Protocol A0221057 was terminated on December 25, 2009 for futility. There were no safety concerns related to this decision.

Conditions

• Healthy

Interventions

• DRUG: fesoterodine fumarate
• DRUG: placebo
• DRUG: solifenacin

Sponsor

Pfizer